Literature DB >> 15350220

Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death.

Cole M Haynes1, Eric A Titus, Antony A Cooper.   

Abstract

A variety of debilitating diseases including diabetes, Alzheimer's, Huntington's, Parkinson's, and prion-based diseases are linked to stress within the endoplasmic reticulum (ER). Using S. cerevisiae, we sought to determine the relationship between protein misfolding, ER stress, and cell death. In the absence of ERV29, a stress-induced gene required for ER associated degradation (ERAD), misfolded proteins accumulate in the ER leading to persistent ER stress and subsequent cell death. Cells alleviate ER stress through the unfolded protein response (UPR); however, if stress is sustained the UPR contributes to cell death by causing the accumulation of reactive oxygen species (ROS). ROS are generated from two sources: the UPR-regulated oxidative folding machinery in the ER and mitochondria. Our results demonstrate a direct mechanism(s) by which misfolded proteins lead to cellular damage and death. Copyright 2004 Cell Press

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350220     DOI: 10.1016/j.molcel.2004.08.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  228 in total

1.  Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation.

Authors:  Ru-Feng Wu; Zhenyi Ma; Zhe Liu; Lance S Terada
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

Review 2.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

3.  Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.

Authors:  Ubaldo E Martinez-Outschoorn; Casey Trimmer; Zhao Lin; Diana Whitaker-Menezes; Barbara Chiavarina; Jie Zhou; Chengwang Wang; Stephanos Pavlides; Maria P Martinez-Cantarin; Franco Capozza; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Jaime Caro; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2010-09-09       Impact factor: 4.534

Review 4.  Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis.

Authors:  Giovanni Manfredi; Hibiki Kawamata
Journal:  Neurobiol Dis       Date:  2015-08-15       Impact factor: 5.996

Review 5.  Programmed Cell Death Initiation and Execution in Budding Yeast.

Authors:  Randy Strich
Journal:  Genetics       Date:  2015-08       Impact factor: 4.562

6.  CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.

Authors:  J Tang; Y-S Guo; Y Zhang; X-L Yu; L Li; W Huang; Y Li; B Chen; J-L Jiang; Z-N Chen
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

Review 7.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.

Authors:  Alla V Glushchenko; Donald W Jacobsen
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

Review 8.  Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.

Authors:  Palsamy Periyasamy; Toshimichi Shinohara
Journal:  Prog Retin Eye Res       Date:  2017-08-31       Impact factor: 21.198

Review 9.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

10.  TRNA mutations that affect decoding fidelity deregulate development and the proteostasis network in zebrafish.

Authors:  Marisa Reverendo; Ana R Soares; Patrícia M Pereira; Laura Carreto; Violeta Ferreira; Evelina Gatti; Philippe Pierre; Gabriela R Moura; Manuel A Santos
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.